[ad_1]
New York, June 20, 2021 (Global News Service) – Pomerantz LLP is investigating claims on behalf of investors of Vascular Biogenics Ltd. (“VBL” or “Company”) (NASDAQ: VBLT). It is recommended that such investors contact Robert S. Willoughby newaction@pomlaw.com Or 888-476-6529, ext. 7980.
The investigation involves whether Vascular and some of its officers and/or directors are engaged in securities fraud or other illegal business practices.
[Click here for information about joining the class action]
On June 15, 2021, VBL issued a press release “Providing[ing] An update of its ongoing OVAL Phase 3 study, investigating ranergene obadenovec (VB-111),…
The full story on Benzinga.com
[ad_2]
Source link
